CSTL

Castle Biosciences (CSTL)

Castle Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CSTL

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/28	06:13	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CSTL	Castle Biosciences Inc
2025/02/28	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CSTL	Castle Biosciences Inc
2025/02/28	06:05	Business Wire	Castle Biosciences Reports Fourth Quarter and Full-Year 2024 Results	NASDAQ:CSTL	Castle Biosciences Inc
2025/02/26	06:30	Business Wire	Castle Biosciences to Participate in Upcoming Investor Conferences	NASDAQ:CSTL	Castle Biosciences Inc
2025/02/25	06:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2025/02/13	06:30	Business Wire	Castle Biosciences to Share Data Reinforcing the Clinical Value of Its Dermatologic Portfolio of Gene Expression Profile Tests at the 22nd Annual Winter Clinical Dermatology Conference - Hawaii®	NASDAQ:CSTL	Castle Biosciences Inc
2025/02/06	21:00	Business Wire	Castle Biosciences to Release Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call on Thursday, Feb. 27, 2025	NASDAQ:CSTL	Castle Biosciences Inc
2025/01/17	21:00	Business Wire	Castle’s Poster on DecisionDx®-SCC Selected as a “Late Breakers” Top Five Finalist for the Akamai Award, Recognizing the Best Posters at Maui Derm Hawaii 2025	NASDAQ:CSTL	Castle Biosciences Inc
2025/01/13	08:00	Business Wire	Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Results	NASDAQ:CSTL	Castle Biosciences Inc
2025/01/09	08:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2025/01/07	06:29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CSTL	Castle Biosciences Inc
2025/01/06	21:00	Business Wire	Castle Biosciences Announces New York State Department of Health Approval of Its TissueCypher® Barrett’s Esophagus Test	NASDAQ:CSTL	Castle Biosciences Inc
2024/12/23	21:00	Business Wire	Castle Biosciences Highlights Progress for its Pipeline Atopic Dermatitis Gene Expression Profile Test	NASDAQ:CSTL	Castle Biosciences Inc
2024/12/19	21:00	Business Wire	Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:CSTL	Castle Biosciences Inc
2024/12/12	21:00	Business Wire	Independent Systematic Review and Meta-Analysis Attests to the Significant Risk Stratification Provided by Castle Biosciences’ DecisionDx®-Melanoma Test, Contributing to Personalized Management of Patients with Melanoma	NASDAQ:CSTL	Castle Biosciences Inc
2024/12/12	06:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/12/12	06:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/12/12	06:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/11/20	21:00	Business Wire	Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference	NASDAQ:CSTL	Castle Biosciences Inc
2024/11/20	06:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/11/19	21:00	Business Wire	Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year	NASDAQ:CSTL	Castle Biosciences Inc
2024/11/15	03:39	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/11/08	21:00	Business Wire	Castle Biosciences to Present New Data Highlighting the Clinical Performance of DecisionDx®-Melanoma and MyPath® Melanoma at the American Society of Dermatopathology 61st Annual Meeting	NASDAQ:CSTL	Castle Biosciences Inc
2024/11/08	06:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/11/07	21:00	Business Wire	Castle Biosciences Surpasses 25,000 Test Reports Delivered for its TissueCypher® Barrett’s Esophagus Test	NASDAQ:CSTL	Castle Biosciences Inc
2024/11/06	21:00	Business Wire	Use of Castle Biosciences’ DecisionDx®-Melanoma Test Significantly Reduces Unnecessary SLNB Procedures, Latest Findings from Prospective, Multicenter DECIDE Study Presented at Dermato-Onco2024	NASDAQ:CSTL	Castle Biosciences Inc
2024/11/06	06:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/11/05	06:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CSTL	Castle Biosciences Inc
2024/11/05	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CSTL	Castle Biosciences Inc
2024/11/05	06:05	Business Wire	Castle Biosciences Reports Third Quarter 2024 Results	NASDAQ:CSTL	Castle Biosciences Inc